Recent Advancements in the Diagnosis and Treatment of Gastrointestinal Cancers

Approximately 19.3 million new cases of cancer were diagnosed worldwide in 2020, of which 5 million were cancers of the gastrointestinal (GI) tract. Furthermore, GI cancers were the cause of more than one-third of all cancer-related deaths.1 In 2022, the estimated incidence of cancers of the digestive system (343,040) in the United States will surpass the incidence of breast cancers (290,560) and cancers of the respiratory system (254,850).2 Although recent trends in incidence and mortality rates have been encouraging for cancers of the colorectum and stomach, no improvements have been observed in cancers of the esophagus, liver and intrahepatic bile ducts, and pancreas.
Source: Gastroenterology Clinics of North America - Category: Gastroenterology Authors: Tags: Preface Source Type: research